---
figid: PMC10532491__jfb-14-00466-g005
figtitle: EGFR signal transduction pathway—an overview (modified after [94])
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10532491
filename: PMC10532491__jfb-14-00466-g005.jpg
figlink: /pmc/articles/PMC10532491/figure/F5
number: F5
caption: 'EGFR signal transduction pathway—an overview (modified after [94]). Abbreviations:
  gp130, glycoprotein 130; IL-6, interleukin-6; JAK, Janus kinase; STAT, signal transduction
  and activator of transcription; EGFR, epidermal growth factor receptor; EGFR-TKI,
  epidermal growth factor receptor tyrosine kinase inhibitor; (K)RAS, GTPase KRas;
  (B)RAF, B-Raf proto-oncogene serine/threonine-protein kinase; MEK, mitogen-activated
  protein kinase kinase 1; PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase
  catalytic subunit alpha/beta/delta; AKT, RAC serine/threonine-protein kinase; mTOR,
  mechanistic target of rapamycin; PTEN, phosphatase and tensin homolog; MDM2, mouse
  double minute-2 homolog; TP53, tumor protein 53; EMT, epithelial–mesenchymal transition;
  RB1, epithelial–mesenchymal transition; HER2, human epidermal growth factor receptor
  2; FGFR, fibroblast growth factor receptor; MET, proto-oncogene tyrosine-protein
  kinase Met; RET, proto-oncogene tyrosine-protein kinase Ret; ALK, anaplastic lymphoma
  kinase; NTRK, neurotrophic tyrosine receptor kinase; HER3, human epidermal growth
  factor receptor 3; TROP2, trophoblast cell-surface antigen 2.'
papertitle: Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
reftext: Andreea Crintea, et al. J Funct Biomater. 2023 Sep;14(9):466.
year: '2023'
doi: 10.3390/jfb14090466
journal_title: Journal of Functional Biomaterials
journal_nlm_ta: J Funct Biomater
publisher_name: MDPI
keywords: lung cancer | EGFR | non-small cell lung cancer | nanotherapy
automl_pathway: 0.9204526
figid_alias: PMC10532491__F5
figtype: Figure
redirect_from: /figures/PMC10532491__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10532491__jfb-14-00466-g005.html
  '@type': Dataset
  description: 'EGFR signal transduction pathway—an overview (modified after [94]).
    Abbreviations: gp130, glycoprotein 130; IL-6, interleukin-6; JAK, Janus kinase;
    STAT, signal transduction and activator of transcription; EGFR, epidermal growth
    factor receptor; EGFR-TKI, epidermal growth factor receptor tyrosine kinase inhibitor;
    (K)RAS, GTPase KRas; (B)RAF, B-Raf proto-oncogene serine/threonine-protein kinase;
    MEK, mitogen-activated protein kinase kinase 1; PIK3CA, phosphatidylinositol-4,5-bisphosphate
    3-kinase catalytic subunit alpha/beta/delta; AKT, RAC serine/threonine-protein
    kinase; mTOR, mechanistic target of rapamycin; PTEN, phosphatase and tensin homolog;
    MDM2, mouse double minute-2 homolog; TP53, tumor protein 53; EMT, epithelial–mesenchymal
    transition; RB1, epithelial–mesenchymal transition; HER2, human epidermal growth
    factor receptor 2; FGFR, fibroblast growth factor receptor; MET, proto-oncogene
    tyrosine-protein kinase Met; RET, proto-oncogene tyrosine-protein kinase Ret;
    ALK, anaplastic lymphoma kinase; NTRK, neurotrophic tyrosine receptor kinase;
    HER3, human epidermal growth factor receptor 3; TROP2, trophoblast cell-surface
    antigen 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - IL6ST
  - NM
  - LRPPRC
  - EGFR
  - ATP8A2
  - ERBB2
  - RET
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - ALK
  - ERBB3
  - TACSTD2
  - NTRK1
  - NTRK2
  - NTRK3
  - MMUT
  - APRT
  - MFAP1
  - AXL
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - NRAS
  - PIK3CA
  - PTEN
  - BRAF
  - AKT1
  - AKT2
  - AKT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - FUS
  - MDM2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - TP53
  - ITK
  - SLC22A3
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - RB1
  - RBM45
  - nucleus
  - ATP
  - MET
  - MEK
  - cancer
---
